There is no time to waste if we are to translate these exciting clinical trial results into actual public health impact and expand the toolbox ... Jun 22
The curfew has been enforced from April 12, 9 PM till April 19, 6 am... Apr 13
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug, Truvada Tablets, 200 mg/300 mg, of Gilead Sciences... Jan 15
Gilead and Galapagos will continue to investigate the potential for filgotinib to support patients living with Inflammatory Bowel Disease... Dec 16
With Remdesivir out from benchmark drugs for Covid Gilead could be severely impacted... Nov 21
Currently no evidence that it improves survival and other important measures ... Nov 20
... Nov 07
WHO-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but shunning Gilead's GILD.... Nov 06
The agreement will enter into force as of 1st January 2021... Oct 27
The search for effective drug continues for severely affected Covid patients... Oct 17
Another Indian company joins Remdesivir production... Sep 15
Gilead Sciences, Inc. collaborates with Jounce Therapeutics, Inc., focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers... Sep 02
The collaboration excludes Tango’s lead programs, including one program that is expected to be in investigational new drug (IND) applicatation-enabling studies next year... Aug 19
Now Everest Organics will also manufacture Ramdesivir API... Aug 12
Gufic Lifesciences has entered into a loan agreement with Hetero Labs Limited to manufacture and supply Remdesivir lyophilised powder ... Aug 12
Now Jubiliant launches Remdesivir at Rs 4700... Aug 04
Hetero gears up to deliver Remdesivir doses in India... Jul 16
Mylan will manufacture remdesivir in India and would sell at Rs4,800 which is 80% less than the price in developed countries... Jul 10
US books all Remdesivir produced by Gilead Sciences leaving nothing for others... Jul 02
The Institute for Clinical and Economic Review (ICER) said its recommendation change stemmed from recent clinical data, updated cost estimates & public comments... Jun 25
Hetero launches Remdesivir generic named Covifor for Indian markets ... Jun 23
Remdesivir and HCQ is a deadly combination, reports US FDA... Jun 17
Health Ministry drops Azithromycin, suggest HCQ and Remdesivir instead for COVID patients... Jun 15
Cipla Enters Into a Licensing Agreement With Gilead to Expand Access to COVID-19 Treatment ... May 13
Under the licensing agreements, the companies have a right to receive a technology transfer of the Gilead Sciences manufacturing process for remdesivir to enable them ... May 13
-Advertisements-
.jpeg)
Friday, November 22, 2024
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)